Inceptor Bio, LLC.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Inceptor Bio, LLC. - overview
Established
2020
Location
Morrisville, NC, US
Primary Industry
Biotechnology
About
Founded in 2020 and based in North Carolina, US, and founded in 2020 by its CEO, Shailesh Maingi, Inceptor Bio, LLC, operates as a provider of gene therapy technology platforms. In May 2022, Inceptor Bio, LLC. raised USD 37 million in series A funding led by returning investor Kineticos Ventures. As of 2022, the company has its manufacturing facilities in Gainesville and Florida.
The company offers various platforms for the prevention and treatment of cancer through multiple cell therapies that include CAR-Macrophages, CAR-Natural Killer cells, and Gamma Delta T cells, CAR-T cells, which are used to locate and nullify cancer cells. The company also provides gene editing in vivo or ex vivo used to cure patients. The company plans to use the May 2022 funding to support the development of the CAR-T lead program, CAR-M, and CAR-NK platforms.
Current Investors
Kineticos Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Website
www.inceptor.bio
Company Stage
Series A
Total Amount Raised
Subscriber access only
Inceptor Bio, LLC. - employee data
Inceptor Bio, LLC. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman Of The Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.